New Parkinson's drug candidate has roots in a Rockefeller lab
October 23, 2026
October 23, 2026
NEW YORK, Oct. 23 -- Rockefeller University posted the following news:
* * *
New Parkinson's drug candidate has roots in a Rockefeller lab
*
Earlier this month, the biotech company Cerevance announced that its experimental Parkinson's drug, solengepras, had succeeded in a large phase 3 clinical trial. Adding a once-daily solengepras pill to their usual medication regimen gave people with Parkinson's more time each day with their . . .
* * *
New Parkinson's drug candidate has roots in a Rockefeller lab
*
Earlier this month, the biotech company Cerevance announced that its experimental Parkinson's drug, solengepras, had succeeded in a large phase 3 clinical trial. Adding a once-daily solengepras pill to their usual medication regimen gave people with Parkinson's more time each day with their . . .